Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Hypersensitivity × Sodium Chloride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Severe Acute Respiratory Syndrome 1 Neoplasms 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mastocytosis 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia, Hairy Cell 1 Leukemia 1 Hypersensitivity 1 Hodgkin Disease 1 Gliosarcoma 1 Glioblastoma 1 Fatigue 1 Colorectal Neoplasms 1 COVID-19 1

Interventions

Sodium Chloride 1 BNT162 Vaccine 1 2019-nCoV Vaccine mRNA-1273 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04761822 2025-08-12

SARS

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Completed

746 enrolled 28 charts

COVID-19, Hypersensitivity, Mastocytosis, Severe Acute Respiratory Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡